Induction of bilirubin clearance by the constitutive androstane receptor (CAR)

被引:314
作者
Huang, WD
Zhang, J
Chua, SS
Qatanani, M
Han, YQ
Granata, R
Moore, DD
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Univ Turin, Molinette Mauriziano Hosp, Lab Mol & Cellular Endocrinol, Div Endocrinol,Dept Internal Med, I-10126 Turin, Italy
关键词
D O I
10.1073/pnas.0630614100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bilirubin clearance is one of the numerous important functions of the liver. Defects in this process result in jaundice, which is particularly common in neonates. Elevated bilirubin levels can be decreased by treatment with phenobarbital. Because the nuclear hormone receptor constitutive androstane receptor (CAR) mediates hepatic effects of this xenobiotic inducer, we hypothesized that CAR could be a regulator of bilirubin clearance. Activation of the nuclear hormone receptor CAR increases hepatic expression of each of five components of the bilirubin-clearance pathway. This induction is absent in homozygous CAR null mice but is observed in mice expressing human CAR instead of mouse CAR. Pretreatment with xenobiotic inducers markedly increases the rate of clearance of an exogenous bilirubin load in wild-type but not CAR knockout animals. Bilirubin itself can also activate CAR, and mice lacking CAR are defective in clearing chronically elevated bilirubin levels. Unexpectedly, CAR expression is very low in livers of neonatal mice and humans. We conclude that CAR directs a protective response to elevated bilirubin levels and suggest that a functional deficit of CAR activity may contribute to neonatal jaundice.
引用
收藏
页码:4156 / 4161
页数:6
相关论文
共 46 条
[1]   The glucocorticoid receptor is required for stress erythropoiesis [J].
Bauer, A ;
Tronche, F ;
Wessely, O ;
Kellendonk, C ;
Reichardt, HM ;
Steinlein, P ;
Schütz, G ;
Beug, H .
GENES & DEVELOPMENT, 1999, 13 (22) :2996-3002
[2]  
BERGMAN DA, 1994, PEDIATRICS, V94, P558
[3]   MEASUREMENT OF RED BLOOD-CELL LIFE-SPAN [J].
BROUILLARD, RP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (09) :1304-1305
[4]   DEVELOPMENT OF HUMAN-LIVER UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, M ;
JACKSON, M ;
HARDING, D ;
FOURNELGIGLEUX, S ;
LEAKEY, J ;
HUME, R .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1989, 13 (2-4) :70-77
[5]  
CARTER K, 2001, MMWR-MORBID MORTAL W, V50, P491
[6]  
CATZ C, 1962, AM J DIS CHILD, V104, P516
[7]   Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 [J].
Cui, Y ;
König, J ;
Leier, I ;
Buchholz, U ;
Keppler, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :9626-9630
[8]   Drug therapy: Neonatal hyperbilirubinemia. [J].
Dennery, PA ;
Seidman, DS ;
Stevenson, DK .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (08) :581-590
[9]   Recurrence of kernicterus in term and near-term infants in Denmark [J].
Ebbesen, F .
ACTA PAEDIATRICA, 2000, 89 (10) :1213-1217
[10]   Neonatal and adult human heart tissues from normal subjects and patients with ischemic, dilated or hypertrophic cardiomyopathy express insulin-like growth factor binding protein-3 (IGFBP-3) [J].
Granata, R ;
Broglio, F ;
Migliorino, D ;
Cutrupi, S ;
Baldanzi, G ;
Sireno, M ;
Fubini, A ;
Graziani, A ;
Ghigo, E ;
Pucci, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (11) :724-726